-
2023-507407-59-00
5
2024-07-04
Chronic Obstructive Pulmonary Disease (COPD)
-
2024-511959-18-01
5
2024-07-01
Acute Pulmonary Embolism
-
2023-509551-14-00
5
2024-06-12
Unresectable left sided RAS/B-RAF wild-type metastatic colorectal canc
-
2023-507751-30-00
9
2024-05-27
relapsed or refractory multiple myeloma
-
2023-507871-23-00
5
2024-05-27
Relapsed/Refractory Multiple Myeloma
-
2023-503219-14-01
10
2024-05-22
systemic sclerosis associated interstitial lung disease
-
2023-505929-14-00
5
2024-05-21
Systemic Lupus Erythematosus
-
2022-502276-23-00
5
2024-04-25
JAK2V617F-positive high-risk Polycythemia Vera
-
2023-505660-11-00
5
2024-04-24
Cholangiocarcinoma (LTT, 26.0)
-
2023-504865-21-00
5
2024-04-15
Essential Thrombocythemia patients who have an inadequate response to
-
2023-505871-63-00
5
2024-04-08
ER+, HER2- metastatic breast cancer following endocrine and CDK 4/6 in
-
2023-505221-14-00
4
2024-04-04
Multiple Myeloma
-
2023-507441-29-00
5
2024-02-29
Pneumonia
-
2023-503708-10-00
5
2024-02-20
Locally advanced or metastatic breast cancer
-
2022-502282-24-00
5
2024-02-14
Primary generalized tonic-clonic seizures
-
2022-500531-36-00
4
2024-02-02
Type 1 diabetes mellitus
-
2023-505078-13-00
4
2024-01-16
EXTENSIVE STAGE ‐ EXTRAPULMONARY SMALL CELL CARCINOMA
-
2023-505911-19-00
4
2024-01-05
Acute Myeloid Leukemia
-
2023-503224-66-00
5
2023-10-31
Atrial Fibrillation
-
2023-503295-25-00
10
2023-10-31
Resectable biliary tract cancers
-
2023-504602-11-00
5
2023-10-25
Mild to moderate Alzheimer's disease
-
2022-502281-25-00
5
2023-09-27
Focal Onset Seizures
-
2022-502415-11-00
5
2023-06-16
Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR CM)
-
2024-512878-98-00
9
2023-05-16
Brain Metastasis from Estrogen Receptor Positive, HER-2 Negative
Breas